Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01484678 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
A clinical trial of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy, sponsored by University of Florida.
- Recruiting
- Registry status
- 550
- Enrollment target
- 3
- Study locations
NCT01484678 is a study of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy that is actively recruiting participants, run by University of Florida. The registered enrollment target is 550 participants, above the 401-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (37% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT01484678, a study of Duchenne Muscular Dystrophy and Becker Muscular Dystrophy, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research study is to determine the potential of magnetic resonance imaging, spectroscopy, and whole body imaging to monitor disease progression and to serve as an objective outcome measure for clinical trials in Muscular Dystrophy (MD). The investigators will compare the muscles of ambulatory or non-ambulatory boys/men with DMD with muscles of healthy individuals of the same age and monitor disease progression in those with DMD over a 5-10 year period. The amount of muscle damage and fat that the investigators measure will also be related to performance in daily activities, such as walking and the loss of muscle strength. In a small group of subjects the investigators will also assess the effect of corticosteroid drugs on the muscle measurements. Additionally, the investigators will map the progression of Becker MD following adults with this rare disease. The primary objective is to conduct a multi-centered study to validate the potential of non-invasive magnetic resonance imaging and magnetic resonance spectroscopy to monitor disease progression and to serve as a noninvasive surrogate outcome measure for clinical trials in DMD and BMD. The secondary objective is to characterize the progressive involvement of the lower extremity, upper extremity, trunk/respiratory muscles in boys/men with DMD and BMD guiding clinical trials.
Conditions Studied
Study Locations (3)
Florida
- University of Florida - Gainesville
Oregon
- Oregon Health and Science University - Portland
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2026-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01484678
The ClinicalTrials.gov registry entry for NCT01484678 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 550 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 401-participant average among 48 other Duchenne Muscular Dystrophy trials with a reported enrollment target (37% higher). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Duchenne Muscular Dystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT01484678 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Oregon, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01484678 about?
NCT01484678 is a clinical study titled "Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy". The purpose of this research study is to determine the potential of magnetic resonance imaging, spectroscopy, and whole body imaging to monitor disease progression and to serve as an objective outcome measure for clinical trials in Muscular Dystrophy (MD). The investigators will compare the muscles...
What is the current status of trial NCT01484678?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2020-09-01. Estimated completion is 2026-08-31.
What conditions does trial NCT01484678 study?
This clinical trial studies the following conditions: Duchenne Muscular Dystrophy, Becker Muscular Dystrophy.
Who is sponsoring clinical trial NCT01484678?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01484678 being conducted?
This trial has 3 study locations across Florida, Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Duchenne Muscular Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
RECRUITING · Phase 1
-
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
RECRUITING · Phase 2
-
Phase 2 Study of SAT-3247 in Pediatric Ambulatory Patients
RECRUITING · Phase 2
-
Once Weekly Infant Corticosteroid Trial for DMD
RECRUITING · Phase 4
-
The Duchenne Registry
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.